Topic: biomarker testing
-
Inito's AI Antibodies Aim to Revolutionize At-Home Health Testing
Inito secured a $29 million Series B investment to expand its at-home health diagnostics platform, moving beyond fertility to broader hormone monitoring with lab-level precision. The company's core innovation is using AI to design highly sensitive synthetic antibodies, enabling more accurate exis...
Read More » -
Unlock Longevity: How Data Slows Aging
By 2026, precision medical forecasting will use AI and vast datasets to predict individual risks for major age-related diseases like cancer and Alzheimer's long before symptoms appear. This approach integrates diverse data, including health records and wearable sensor data, to create personalized...
Read More »